Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

2 months ago 2
ARTICLE AD BOX
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
Read Entire Article
  1. Homepage
  2. Finance
  3. Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices

Related

FRANK26….12-29-25…….THE THREE

FRANK26….12-29-25…….THE THREE

4 hours ago 1
MarkZ Highlights: Market Stress, Silver Suppression, and Iraq’s Push Toward 2026

MarkZ Highlights: Market Stress, Silver Suppression, and Ira...

5 hours ago 1
MARKZ: “RV COUNTDOWN ACTIVATED — BIG MOVES UNFOLDING THIS AUGUST!” ⏳🚀🔥 #...

MARKZ: “RV COUNTDOWN ACTIVATED — BIG MOVES UNFOLDING THIS AU...

5 hours ago 1
RIGHT SIDEBAR TOP AD

Trending

1. gypsy rose
2. jalen green
3. sicario
4. robert downey jr
5. shannon sharpe
6. portland
7. christian bale
8. ryan nembhard
9. baddies
10. camila olmos

Popular

Gene Hackman’s Wife Died at Least a Day Later Than Originally Thought

Gene Hackman’s Wife Died at Least a Day Later Than Originall...

9 months ago 558
CPF Savings In 2025. Top Up to MA.

CPF Savings In 2025. Top Up to MA.

11 months ago 556
CVC Capital Partners Half Year 2024 Report Analysis

CVC Capital Partners Half Year 2024 Report Analysis

1 year ago 548
Buying a Car? Trump’s Tariffs Could Make It More Expensive.

Buying a Car? Trump’s Tariffs Could Make It More Expensive.

9 months ago 548
Nvidia GTC 2025: What to expect from Nvidia's biggest event of the year

Nvidia GTC 2025: What to expect from Nvidia's biggest event ...

9 months ago 484
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© GKII Finance & Investment Blog 2025. All rights are reserved